Found 5 matching trials
Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial
PHASE3Objective: to evaluate the efficacy and safety of intra-arterial intrathrom...
Location
Kursk city emergency hospital
Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset
PHASE3Multicenter, double-blind, randomized, placebo-controlled phase III clinica...
Location
Ryazan Regional Clinical Hospital
Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE
PHASE3Objective: to evaluate the efficacy and safety of the Recombinant Non-immun...
Location
V.F. Dolgopolov Vyselki Central District Hospital
Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism
PHASE3Objective: to evaluate the efficacy and safety of the non-immunogenic recom...
Location
RZD Medicine hospital
Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF Trial
PHASE2Objective: to evaluate the tolerability, safety and efficacy of inhaled usa...
Location
City Clinical Hospital No.52